Follow
Hemi Dimant
Hemi Dimant
Director, Applications at Invicro
Verified email at invicro.com
Title
Cited by
Cited by
Year
Exosome-associated AAV vector as a robust and convenient neuroscience tool
E Hudry, C Martin, S Gandhi, B György, DI Scheffer, D Mu, SF Merkel, ...
Gene therapy 23 (4), 380-392, 2016
1432016
Direct detection of alpha synuclein oligomers in vivo
H Dimant, SK Kalia, LV Kalia, LN Zhu, L Kibuuka, D Ebrahimi-Fakhari, ...
Acta neuropathologica communications 1, 1-10, 2013
682013
Molecular chaperones and co-chaperones in Parkinson disease
H Dimant, D Ebrahimi-Fakhari, PJ McLean
The Neuroscientist 18 (6), 589-601, 2012
612012
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging
C Mazur, B Powers, K Zasadny, JM Sullivan, H Dimant, F Kamme, ...
JCI insight 4 (20), 2019
602019
Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss
NR McFarland, H Dimant, L Kibuuka, D Ebrahimi-Fakhari, CA Desjardins, ...
PloS one 9 (1), e86048, 2014
472014
Direct Visualization of CHIP-Mediated Degradation of Alpha-Synuclein In Vivo: Implications for PD Therapeutics
H Dimant, L Zhu, LN Kibuuka, Z Fan, BT Hyman, PJ McLean
PLoS One 9 (3), e92098, 2014
192014
Modulation effect of filamentous phage on α-synuclein aggregation
H Dimant, N Sharon, B Solomon
Biochemical and biophysical research communications 383 (4), 491-496, 2009
122009
Synthesis of tetrafurcated dendritic units on solid support
A Dahan, H Dimant, M Portnoy
Journal of Combinatorial Chemistry 6 (3), 305-307, 2004
92004
Filamentous phages reduce α-Synuclein Oligomerization in the membrane fraction of SH-SY5Y cells
H Dimant, B Solomon
Neurodegenerative Diseases 7 (1-3), 203-205, 2010
82010
TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants
S Orgad, H Dimant, E Dor-On, R Azriel-Rosenfeld, I Benhar, B Solomon
Journal of Immunotherapy 33 (2), 146-154, 2010
42010
Abstract LB-366: Cryo-fluorescence tomography as a new tool in 3D visualization of tumor heterogeneity, metastatic proliferation and immuno-oncology
M Brevard, M Farhoud, H Dimant, G Sahagian, E Rosenthal, QD Nguyen
Cancer Research 78 (13_Supplement), LB-366-LB-366, 2018
12018
Macrophage tracking using multi-modality 3D imaging in xenografts
H Dimant, P McConville, K Orcutt, K Mikule, K Wilcoxen, D Lister, ...
Cancer Research 80 (16_Supplement), 381-381, 2020
2020
Quanticell™, a novel histopathology technology for visualization and quantitation of membrane PSMA demonstrated in cell lines and clinical tissue
H Dimant, A Gandhi, M Maker, A Markman, J Reinhardt, S Collins, ...
Cancer Research 80 (16), 2020
2020
Abstract LB-329: Multiple-resolution characterization of tumor heterogeneity as associated with disease progression in a mouse model of colorectal cancer
M Farhoud, A Leystra, DM Albrecht, M Brevard, H Dimant, R Holt, ...
Cancer Research 78 (13_Supplement), LB-329-LB-329, 2018
2018
Multiple-resolution characterization of tumor heterogeneity as associated with disease progression in a mouse model of colorectal cancer
M Farhoud, A Leystra, DM Albrecht, M Brevard, H Dimant, R Holt, ...
CANCER RESEARCH 78 (13), 2018
2018
Cryo-fluorescence Tomography as a new tool in 3D visualization of tumor heterogeneity, metastatic proliferation and immuno-oncology.
M Brevard, M Farhoud, H Dimant, R Holt, EL Rosenthal, G Sahagian, ...
CANCER RESEARCH 78 (13), 2018
2018
Author Index Vol. 7, No. 1–3, 2010
D Uberti, G Cenini, SA Bonini, M Barcikowska, M Styczynska, A Szybinska, ...
Neurodegenerative Diseases 7 (1-3), 216-216, 2010
2010
Intrinsic Anti-aggregating Properties of Filamentous Phages: Implications Towards Treatment of Α-synucleinopathies
H Dimant
Tel Aviv University, 2010
2010
P3. 004 Modulation of alpha synuclein aggregation by fllamentous phages
H Dimant, N Sharon, B Solomon
Parkinsonism and Related Disorders, S148, 2009
2009
The system can't perform the operation now. Try again later.
Articles 1–19